Archive

MS not associated with COVID-19 relapse after vaccination

Written by Bruce Sylvester | 15 Aug 2024

People with multiple sclerosis (MS) do not appear to be at an increased risk of relapse after COVID-19 vaccination, researchers reported on August 14, 2024 in Neurology. “People… read more.

Timing of COVID-19 shot can change menstrual cycle length

Written by Charlie King | 4 Mar 2024

Oregon Health & Science University researchers have confirmed that the timing of COVID-19 vaccination is associated with slight, temporary changes in menstrual cycle length. The study, published today… read more.

Vaccination before Covid-19 infection significantly reduces risk of long covid

Written by Bruce Sylvester | 25 Nov 2023

Covid-19 vaccination prior to infection significantly reduces the risk of developing post-covid-condition (PCC), commonly known as long covid, researchers reported on Nov. 22, 2023 in The BMJ/British Medical… read more.

Does COVID-19 or COVID-19 vaccination worsen migraines?

Written by Charlie King | 2 Nov 2023

Research published in the European Journal of Neurology indicates that COVID-19 and COVID-19 vaccination have negligible effects on migraine severity. Among 550 adults who had received migraine-related care at a… read more.

Global study finds some women experience heavier menstrual flow after COVID-19 vaccination

Written by Charlie King | 19 Apr 2023

A new international study finds that women vaccinated for COVID-19 have a slightly higher risk for a heavier period after vaccination. The study, led by Oregon Health &… read more.

Covid-19 vaccine not linked with period disruption, study finds

Written by Charlie King | 5 Apr 2023

Covid-19 vaccination does not cause concerning changes to periods, research has found. Women who have been infected with the Covid-19 virus are, however, at increased risk of menstrual… read more.

COVID-19 vaccine acceptance increased globally in 2022

Written by Charlie King | 13 Jan 2023

Global willingness to accept a COVID-19 vaccine increased from 75.2% in 2021 to 79.1% in 2022, according to a new survey of 23 countries that represent more than 60% of… read more.

Text messaging shows promise in reaching unvaccinated patients

Written by Charlie King | 16 Jun 2022

Automated text messaging was as effective as direct phone calls in getting unvaccinated patients to seek out a COVID-19 shot, according to a new study from the Perelman… read more.

Third dose of COVID-19 vaccine does not appear to increase severe adverse events

Written by Bruce Sylvester | 7 May 2022

Investigators report that even though there was some increase in cases of low-severity adverse events after third-dose vaccination against SARS-CoV-2 infection with mRNA vaccines, such third-dose vaccination did… read more.

COVID vaccination linked to hair loss

Written by Christine Clark | 30 Mar 2022

A report of nine cases of alopecia areata (AA) following SARS-CoV-2 vaccination appears to confirm suspicions that mRNA vaccines can trigger autoimmune responses that lead to hair loss…. read more.

FDA Advisory Committee unanimously votes in support of emergency use for a booster dose of Moderna’s COVID-19 Vaccine in the U.S

Written by Charlie King | 27 Oct 2021

Moderna, Inc. confirmed that the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommended that the FDA grant an Emergency Use Authorization (EUA) for a booster dose… read more.

Archive

Subscribe for our mailing list

Follow Us